HomeLatest ThreadsGreatest ThreadsForums & GroupsMy SubscriptionsMy Posts
DU Home » Latest Threads » Forums & Groups » Places » International » Latin America (Group) » Argentina: Severe COVID-1...

Mon May 10, 2021, 11:07 PM

Argentina: Severe COVID-19 patients treated with CoviFab horse serum show 90% less ICU need

Authorities from the Argentine pharmaceutical firm Inmunova released data today showing a 90% reduction in the need for intensive care in patients with severe COVID-19 symptoms who were treated with the firm's CoviFab equine serum.

Inmunova reported that 90% of 1805 COVID-19 patients as of April 26th - including 80% who had pneumonia and required oxygen - no longer required intensive care after treatment with CoviFab.

Fewer than 10% of the treated patients required Mechanical Respiratory Assistance (MRA), and the mortality rate observed among them was 8.9%.

Findings published in The Lancet's EClinicalMedicine journal on April 12th, among 245 patients in clinical trials from August through October 2020, a 44.5% mortality decline in severe cases was seen compared to the placebo group - as well as an improvement in recovery times.

Since its approval for public use by Argentina's FDA counterpart, ANMAT, in January, CoviFab equine serum has been used for over 3,000 Argentine COVID-19 patients in 54 hospitals in 17 provinces - predominantly severe cases.

“The use of treatment has increased dramatically,” Dr. Fernando Goldbaum, founding partner and scientific director at Inmunova, noted.

“We register its administration to 100 new patients every day. Buenos Aires Province (the nation's largest) distributes them in a massive way through its public hospitals, and in Córdoba it is beginning to be used on a greater scale.”

At: https://translate.google.com/translate?sl=es&tl=en&u=https://www.pagina12.com.ar/340700-el-exito-del-suero-equino-avanza-al-galope



Dr. Fernando Goldbaum, of the Argentine pharmaceutical firm Inmunova, studies a Petri dish with a fellow researcher in January.

Since Argentina's approval of Inmunova's CoviFab horse serum that month, over 3,000 mainly severe COVID-19 patients nationwide have received the treatment - with most showing substantial improvement.

The country is nevertheless struggling with 260,000 active cases - with around 20,000 new cases and 433 deaths daily.

3 replies, 260 views

Reply to this thread

Back to top Alert abuse

Always highlight: 10 newest replies | Replies posted after I mark a forum
Replies to this discussion thread
Arrow 3 replies Author Time Post
Reply Argentina: Severe COVID-19 patients treated with CoviFab horse serum show 90% less ICU need (Original post)
peppertree May 10 OP
Judi Lynn May 10 #1
peppertree May 10 #2
PoindexterOglethorpe May 10 #3

Response to peppertree (Original post)

Mon May 10, 2021, 11:26 PM

1. Amazing. Who would have been able to predict this? Winter may seem less terrifying this year.

Such positive results. Wow.

What a gift this will be to those suffering right now.

Most people still don't really seem to grasp the destructiveness of this illness unless it affects them personally. It can save their lives, too!

Thank you, peppertree!

Reply to this post

Back to top Alert abuse Link here Permalink


Response to Judi Lynn (Reply #1)

Mon May 10, 2021, 11:33 PM

2. You're welcome, Judi. Sounds promising for Argentina - and indeed, the world

Here's hoping greed and politics don't get in the way of this treatment being made to anyone around the world who wants it.

Reply to this post

Back to top Alert abuse Link here Permalink


Response to peppertree (Original post)

Mon May 10, 2021, 11:56 PM

3. Is this really a valid study?

Reply to this post

Back to top Alert abuse Link here Permalink

Reply to this thread